Presentation slides and video from the 2017 Advances in Cancer Immunotherapy™ - Washington, DC held on October 7, 2017 are available here.Program Organizers
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Nursing Perspective on irAEs: Patient Education, Monitoring, and Management; Presenter: Karin Choquette, MSN, RN, CCRC - Virginia Cancer Specialists; Date: October 7, 201700:22:54
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy Practice; Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Geoffrey T. Gibney, MD - Georgetown-Lombardi Comprehensive Cancer Center; Date: October 7, 201700:29:08
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Management and Mitigation of irAEs for Immunotherapy Prescribers; Presenter: Elizabeth M. Gaughan, MD - University of Virginia; Date: October 7, 201700:17:41
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Mechanisms of immune-Related Adverse Events; Presenter: Stephen Liu, MD - Georgetown-Lombardi Comprehensive Cancer Center; Date: October 7, 201700:23:18
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy Practice; Presentation: Immunotherapy for the Treatment of Genitourinary Cancers; Presenter: James L Gulley, MD PhD, FACP - National Cancer Institute; Date: October 7, 201700:22:15
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy Practice; Presentation: Immunotherapy for the Treatment of Head and Neck Cancers; Presenter: Ann W. Gramza, MD - Georgetown-Lombardi Comprehensive Cancer Center; Date: October 7, 201700:17:48
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy Practice; Presentation: Immunotherapy for the Treatment of Lung Cancer; Presenter: Alexander Spira, MD, PhD, FACP - Virginia Cancer Specialists; Date: October 7, 201700:22:41
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy Practice; Presentation: Basic Principles of Cancer Immunotherapy; Presenter: Michael B. Atkins, MD - Georgetown-Lombardi Comprehensive Cancer Center; Date: October 7, 201700:35:51
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy into Community Practice; Presentation: Coverage and Reimbursement Challenges and Strategies; Presenter: Alexander Spira, MD, PhD, FACP - Virginia Cancer Specialists; Date: October 7, 201700:11:13
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy into Community Practice; Presentation: Effective Practices for Incorporating Immunotherapy into Hospital Operations; Presenter: Alexander Spira, MD, PhD, FACP - Virginia Cancer Specialists; Date: October 7, 201700:14:42
Meeting: Advances in Cancer Immunotherapy™- Washington, DC; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Identification and Management of Immune-Related Adverse Events in the Emergency Setting; Presenter: Sarah B. Dubbs, MD, FAAEM - University of Maryland School of Medicine; Date: October 7, 201700:24:39
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us